IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Akari Therapeutics PLC (AKTX)

CUSIP: 00972G207 | US | Healthcare · Biotechnology | Micro Cap | 36 institutional holders

Quarters

Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/ASamir R. Patel9,725,215,00010.4%New 5%+ stakeMar 2, 2026No 13F filer matched
13D/ARay Prudo, M.D.
with RPC Pharma Limited, Praxis Trustees Limited as trustee of the Sonic Healthcare Holding Company

Institutional Holders — Q1 2026

IFP Advisors, Inc7,250
0.0% of portfolio›$877
StyleTurnoverLocationFiled
IFP Advisors, Inc
7,250$8770.0%GrowthLowTampa, FL2026-04-13
8,391,326,467
8.9%
New 5%+ stake
Mar 2, 2026
No 13F filer matched
13D/ASamir R. Patel9,725,215,000
10.4% of class · Mar 2, 2026New 5%+ stake
No 13F filer matched
13D/ARay Prudo, M.D.8,391,326,467
8.9% of class · Mar 2, 2026New 5%+ stake
with RPC Pharma Limited, Praxis Trustees Limited as trustee of the Sonic Healthcare Holding Company
No 13F filer matched